News & Events

Risk of Infection—and Death—for Surgery and Cancer Patients

Oct 15, 2015 | The Lancet Infectious Diseases

Study researchers at the Center for Disease Dynamics, Economics & Policy (CDDEP) estimate that a 30 percent drop in the effectiveness of antibiotics typically administered as a preventive measure to surgery and chemotherapy patients would result in 120,000 additional infections and more than 6,000 additional deaths a year in the U.S. alone. They also found that 39 percent to 51 percent of pathogens that cause surgical infections are resistant to standard antibiotics.

MRSA: The tiny bacteria that can tackle Giants

Oct 12, 2015 | CNN

The deadly MRSA bacteria isn't rare; about two out of 100 people carry it in their noses. Most of the time it's not a problem, but it can be passed to other people, and if it gets into a wound through a break in the skin or through a medical procedure, it can kill quickly. In 2013, nearly 10,000 people died in the United States from MRSA infections, according to the CDC.

News Brief: Four New Verigene Outcomes Studies to be Presented at IDWeek 2015

Oct 5, 2015 | Nanosphere News

Four new outcomes studies associated with implementation of Verigene Gram-Positive (BC-GP) and Gram-Negative (BC-GN) Blood Culture Tests will be presented during IDWeek 2015 in San Diego.

News Brief: Five New Verigene Studies to be Presented at ICAAC 2015

Sep 17, 2015 | Nanosphere News

New clinical data for two Verigene infectious disease tests will be presented during Sepsis Awareness Month at the 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Diego this week.

Flu shot recommended despite last year’s fizzle

Sep 13, 2015 | The Tennessean

H3N2 viruses accounted for 95 percent of all influenza reported to the CDC last year from the U.S. World Health Organization and National Respiratory and Enteric Virus Surveillance System collaborating laboratories. Each year, approximately 5 percent to 20 percent of people in the U.S. get the flu and more than 200,000 people are hospitalized for flu-related complications, according to the Centers for Disease Control and Prevention.

News Brief: Nanosphere Receives FDA Clearance for Verigene RP Flex Test

Sep 8, 2015 | Nanosphere News

Nanosphere announced this week that is has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Verigene® Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) on the automated, sample-to-result Verigene System. The first test of its kind, RP Flex features Nanosphere’s novel Flex™ software, which allows the 16 viral and bacterial targets identified by RP Flex to be reported as a full multiplex panel or in various user-defined subsets. Labs pay for only the targets ordered for each patient sample.